Virtus Investment Advisers’s KalVista Pharmaceuticals KALV Stock Holding History

Virtus Investment Advisers’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-49,927	Closed	-$1.01M	–	486
2026 Q1	$1.01M	Buy	49,927 +9,513	+24%	+$153K	0.28%	141
2025 Q4	$653K	Buy	40,414 +31,721	+365%	+$420K	0.18%	202
2025 Q3	$106K	Buy	8,693 +1,509	+21%	+$20.9K	0.03%	420
2025 Q2	$81.2K	Buy	+7,184	New	+$87.8K	0.03%	418

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtus Investment Advisers's KALV Position: Q2 2026 in Review

Virtus Investment Advisers sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 49,927 shares — an estimated $1.01M sold.

Virtus Investment Advisers first reported a position in KALV in Q2 2025 and held it in 4 quarters. The position peaked at $1.01M in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Virtus Investment Advisers reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Virtus Investment Advisers sold 49,927 KalVista Pharmaceuticals shares in Q2 2026, an estimated $1.01M.
Virtus Investment Advisers first reported a position in KalVista Pharmaceuticals in Q2 2025 and held it in 4 quarters.
Virtus Investment Advisers's KalVista Pharmaceuticals position peaked at $1.01M in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.